Viewing StudyNCT00170209



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00170209
Status: COMPLETED
Last Update Posted: 2017-12-19
First Post: 2005-09-12

Brief Title: Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children P4v9
Sponsor: McGill University
Organization: McGill University

Organization Data

Organization: McGill University
Class: OTHER
Study ID: MCT-44154
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: McGill University
Lead Sponsor Class: OTHER
Responsible Party: Dr Dick Menzies
Responsible Party Title: Director of Respiratory Medicine
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: McGill University
Old Name: None
Old Organization: None

Collaborators

Name Class
Canadian Institutes of Health Research CIHR OTHER_GOV